The purpose of this expanded access program (EAP) is to provide Selexipag (Uptravi) for the treatment of participant with non-healing wound, buerger's disease.
Study Type
EXPANDED_ACCESS
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.